Literature DB >> 15643283

Increased contractile response to phenylephrine in detrusor of patients with bladder outlet obstruction: effect of the alpha1A and alpha1D-adrenergic receptor antagonist tamsulosin.

Kirsten Bouchelouche1, Lisa Andersen, Susana Alvarez, Joergen Nordling, Pierre Bouchelouche.   

Abstract

PURPOSE: Alpha1-adrenergic receptor (alpha1-AR) antagonists are effective for treating patients with lower urinary tract symptoms associated with bladder outlet obstruction (BOO). In humans up-regulation of alpha1-AR function in the detrusor in patients with BOO has been suggested but to our knowledge it is not yet confirmed. We investigated the effect of phenylephrine, an alpha1-AR agonist, on isometric tension in small detrusor muscle biopsies from patients with lower urinary tract symptoms and BOO compared with controls.
MATERIALS AND METHODS: Detrusor biopsies were obtained from 7 men with BOO undergoing prostatectomy and 7 undergoing cystectomy for bladder cancer (controls). Patients were characterized by symptom score and urodynamics. Isometric tension was measured in detrusor biopsies with an especially built mini myograph.
RESULTS: Mean International Prostate Symptom Score +/- SEM in patients with BOO and controls were 22.3 +/- 2.3 and 4.0 +/- 0.8, respectively. Phenylephrine (10(-6) to 10(-3) M) induced a significant contractile response increase in detrusor biopsies from patients with BOO compared with controls at all concentrations. Tamsulosin (0.1 to 3.0 nM) inhibited phenylephrine induced contraction in a dose dependent manner.
CONCLUSIONS: To our knowledge this functional study shows for the first time a highly significant increase in contractile force to phenylephrine in patients with BOO compared with controls. These results suggest up-regulation of alpha1-AR function in BOO since contractile responses were potently inhibited by the alpha1A/D-AR antagonist tamsulosin.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15643283     DOI: 10.1097/01.ju.0000143198.16610.84

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  7 in total

Review 1.  Alpha1-adrenoceptor subtypes and lower urinary tract symptoms.

Authors:  Debra A Schwinn; Claus G Roehrborn
Journal:  Int J Urol       Date:  2008-03       Impact factor: 3.369

2.  Efficacy of alpha-Adrenergic Receptor Blockers in the Treatment of Male Lower Urinary Tract Symptoms.

Authors:  Claus G Roehrborn
Journal:  Rev Urol       Date:  2009

Review 3.  Research Findings on Overactive Bladder.

Authors:  Phani B Patra; Sayani Patra
Journal:  Curr Urol       Date:  2015-05-20

4.  Endogenous N-terminal Domain Cleavage Modulates α1D-Adrenergic Receptor Pharmacodynamics.

Authors:  Timothy S Kountz; Kyung-Soon Lee; Stacey Aggarwal-Howarth; Elizabeth Curran; Ji-Min Park; Dorathy-Ann Harris; Aaron Stewart; Joseph Hendrickson; Nathan D Camp; Alejandro Wolf-Yadlin; Edith H Wang; John D Scott; Chris Hague
Journal:  J Biol Chem       Date:  2016-07-05       Impact factor: 5.157

5.  Effects of Spinal and Peripheral Injection of α1A or α1D Adrenoceptor Antagonists on Bladder Activity in Rat Models with or without Bladder Outlet Obstruction.

Authors:  Jae Heon Kim; Ji Sung Shim; Seung Chul Kang; Kang Soo Shim; Jae Young Park; Du Geon Moon; Jeong Gu Lee; Jae Hyun Bae
Journal:  Int Neurourol J       Date:  2011-12-31       Impact factor: 2.835

6.  A comparison of the efficacy of naftopidil and tamsulosin hydrochloride in medical treatment of benign prostatic enlargement.

Authors:  Chenthil Perumal; Puskar Shyam Chowdhury; N Ananthakrishnan; Prasant Nayak; Srinivasan Gurumurthy
Journal:  Urol Ann       Date:  2015 Jan-Mar

7.  N-glycosylation of α1D-adrenergic receptor N-terminal domain is required for correct trafficking, function, and biogenesis.

Authors:  Eric M Janezic; Sophia My-Linh Lauer; Robert George Williams; Michael Chungyoun; Kyung-Soon Lee; Edelmar Navaluna; Ho-Tak Lau; Shao-En Ong; Chris Hague
Journal:  Sci Rep       Date:  2020-04-29       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.